TY - JOUR
KW - Adult
KW - Adulteration
KW - buprenorphine
KW - Buprenorphine, Naloxone Drug Combination/therapeutic use
KW - Buprenorphine/analogs & derivatives/therapeutic use/urine
KW - Cocaine-Related Disorders/diagnosis/drug therapy/urine
KW - Drug Contamination/prevention & control
KW - Female
KW - Humans
KW - Male
KW - Methadone/therapeutic use
KW - Middle Aged
KW - monitoring
KW - Opioid-Related Disorders/diagnosis/drug therapy/urine
KW - Retention
KW - Substance Abuse Detection/methods/standards
KW - Therapy
AU - S. R. Holt
AU - J. H. Donroe
AU - D. A. Cavallo
AU - J. M. Tetrault
A1 - 
BT - Drug and alcohol dependence
C5 - Opioids & Substance Use
CY - Ireland
JF - Drug and alcohol dependence
PB - Elsevier B.V
PP - Ireland
PY - 2018
SN - 1879-0046; 0376-8716
SP - 171
EP - 174
EP - 
T1 - Addressing discordant quantitative urine buprenorphine and norbuprenorphine levels: Case examples in opioid use disorder
T2 - Drug and alcohol dependence
TI - Addressing discordant quantitative urine buprenorphine and norbuprenorphine levels: Case examples in opioid use disorder
U1 - Opioids & Substance Use
U2 - 29579725
VL - 186
VO - 1879-0046; 0376-8716
Y1 - 2018
ER -